Showing results (121-130 of 1,520) with videos related to
Sort By:
Pageof 152
CPT: Pharmacometrics & Systems Pharmacology|January 15, 2021
Population pharmacokinetic model with time-varying clearance for lorlatinib using pooled data from patients with non-small cell lung cancer and healthy participantsJoseph Chen, Brett Houk, Yazdi K Pithavala, et al.CPT: Pharmacometrics & Systems Pharmacology|January 12, 2017
Database of Optimized Proteomic Quantitative Methods for Human Drug Disposition-Related Proteins for Applications in Physiologically Based Pharmacokinetic ModelingM Vrana, D Whittington, V Nautiyal, et al.CPT: Pharmacometrics & Systems Pharmacology|September 12, 2019
Quantifying Drug-Induced Bone Marrow Toxicity Using a Novel Haematopoiesis Systems Pharmacology ModelChiara Fornari, Lenka Oplustil O'Connor, Carmen Pin, et al.CPT: Pharmacometrics & Systems Pharmacology|September 30, 2022
Comparing the applications of machine learning, PBPK, and population pharmacokinetic models in pharmacokinetic drug-drug interaction predictionJaidip Gill, Marie Moullet, Anton Martinsson, et al.CPT: Pharmacometrics & Systems Pharmacology|October 6, 2022
Joint modeling under competing risks: Application to survival prediction in patients admitted in Intensive Care Unit for sepsis with daily Sequential Organ Failure Assessment score assessmentsAlexandra Lavalley-Morelle, Jean-François Timsit, France Mentré, et al.CPT: Pharmacometrics & Systems Pharmacology|March 14, 2021
Approaches to handling missing or "problematic" pharmacology data: PharmacokineticsDonald J Irby, Mustafa E Ibrahim, Anees M Dauki, et al.CPT: Pharmacometrics & Systems Pharmacology|March 9, 2021
Comprehensive PBPK model to predict drug interaction potential of Zanubrutinib as a victim or perpetratorKun Wang, Xueting Yao, Miao Zhang, et al.CPT: Pharmacometrics & Systems Pharmacology|February 6, 2021
A Mechanistic In Vivo/Ex Vivo Pharmacokinetic-Pharmacodynamic Model of Tenofovir for HIV PreventionPriya Jayachandran, Maria Garcia-Cremades, Katarina Vučićević, et al.CPT: Pharmacometrics & Systems Pharmacology|November 4, 2021
Quantitative systems pharmacology: Landscape analysis of regulatory submissions to the US Food and Drug AdministrationJane P F Bai, Justin C Earp, Jeffry Florian, et al.CPT: Pharmacometrics & Systems Pharmacology|December 24, 2021
A semimechanistic population pharmacokinetic and pharmacodynamic model incorporating autoinduction for the dose justification of TAS-114Hikari Araki, Toru Takenaka, Koichi Takahashi, et al.Pageof 152